Back to search

National and Kapodistrian University of Athens

Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία

Abstract

dc:description

Purpose The expression of various angiogenic factors was assessed in tumour samplesof patients with stage III NSCLC before treatment and further analyzed in relation toresponse to Paclitaxel-Ifosfamide-Cisplatin (TIP) chemotherapy.Methods Freshly isolated lung tumour specimens from 35 NSCLC chemotherapy naïvepatients were sampled and analysed for vascular endothelial growth factor receptor-1(VEGFR-1), VEGFR-2 and VEGFR-3, Tumor necrosis factor-alpha (TNFa), Tumorgrowth factor-beta (TGFb), interleukin-6 (IL6) and IL8, before and after treatment.Immunostaining scores were calculated by multiplying the percentage of labeled cellsby the intensity of staining for each examined parameter.Results The overall expression of VEGF receptors and particularly of VEGFR1 wasdecreased in 68.6% of patients, increased in 22.9% and remained stable in 8.6% afterthe completion of treatment. Similar results were found for VEGFR3 (68.6% decreased,25.7% increased and 5.7% stable). For VEGFR2 there was an important increase of thevalue in 65.7% of patients (p<0.01), as the decrease and stable values were foundsimilar (17%). There were no statistically important differences for all immunologicparameters before and after treatment: TNFa (increase 54.3%, decrease 34.3%, stable20%, p-0.28) TGFb (increase 48.6%, decrease 34.3%, stable 17.1%, p-0.13), but nostatistically important differences for IL6 (increase 34.3%, decrease 28.6%, stable37.1%, p-0.78) and IL8 (increase 26.5%, decrease 32.4% and stable 41.2%, p-0.84).Conclusion Our study identified patterns of angiogenic marker expression withpredictive significance in stage III NSCLC treated with TIP chemotherapy. Thedecrease of VEGFR1 and VEGFR3 after treatment it is probably related to the decreaseof the tumour size, as the increase of VEGFR2 values could be related to high levels ofprecancerous growth factors including VEGF that are released in the circulation afterchemotherapy something that requires futher investigation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koufos, Nikolaos
  • Κουφός, Νικόλαος

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35956

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koufos, Nikolaos; Κουφός, Νικόλαος. Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/35956